Globus Medical A Stock Fundamentals
| GM0N Stock | EUR 78.00 2.00 2.50% |
GLOBUS MEDICAL A fundamentals help investors to digest information that contributes to GLOBUS MEDICAL's financial success or failures. It also enables traders to predict the movement of GLOBUS Stock. The fundamental analysis module provides a way to measure GLOBUS MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GLOBUS MEDICAL stock.
GLOBUS |
GLOBUS MEDICAL A Company Price To Sales Analysis
GLOBUS MEDICAL's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current GLOBUS MEDICAL Price To Sales | 7.57 X |
Most of GLOBUS MEDICAL's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GLOBUS MEDICAL A is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, GLOBUS MEDICAL A has a Price To Sales of 7.5678 times. This is much higher than that of the sector and significantly higher than that of the Other industry. The price to sales for all Germany stocks is notably lower than that of the firm.
GLOBUS MEDICAL A Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GLOBUS MEDICAL's current stock value. Our valuation model uses many indicators to compare GLOBUS MEDICAL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GLOBUS MEDICAL competition to find correlations between indicators driving GLOBUS MEDICAL's intrinsic value. More Info.GLOBUS MEDICAL A is rated below average in current valuation category among its peers. It also is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for GLOBUS MEDICAL A is about 1,607,175,974 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GLOBUS MEDICAL's earnings, one of the primary drivers of an investment's value.GLOBUS Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GLOBUS MEDICAL's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GLOBUS MEDICAL could also be used in its relative valuation, which is a method of valuing GLOBUS MEDICAL by comparing valuation metrics of similar companies.GLOBUS MEDICAL is currently under evaluation in price to sales category among its peers.
GLOBUS Fundamentals
| Current Valuation | 6.66 B | |||
| Price To Book | 4.15 X | |||
| Price To Sales | 7.57 X | |||
| Revenue | 1.02 B | |||
| EBITDA | 304.5 M | |||
| Net Income | 190.17 M | |||
| Cash Flow From Operations | 178.47 M | |||
| Price To Earnings To Growth | 2.80 X | |||
| Number Of Employees | 12 | |||
| Market Capitalization | 6.1 B | |||
| Total Asset | 2.08 B | |||
| Net Asset | 2.08 B |
About GLOBUS MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GLOBUS MEDICAL A's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GLOBUS MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GLOBUS MEDICAL A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in GLOBUS Stock
GLOBUS MEDICAL financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL security.